Intervention not reported
Short‐Form‐36 Health Survey (SF‐36) score at 3 months Scale from: 0 to 100 (higher is better). · people with amyotrophic lateral sclerosis or motor neuron disease
1 finding from 1 review
Intervention not reported
Upper extremity maximum voluntary isometric contraction score at 3 months Quantitative Muscle Assessment (QMA) system. Data were normalized, summed and averaged to yield an U/E megascore (higher is better). · people with amyotrophic lateral sclerosis or motor neuron disease
1 finding from 1 review
Intervention not reported
Lower extremity maximum voluntary isometric contraction score at 3 months Quantitative Muscle Assessment (QMA) system. Data were normalized, summed and averaged to yield a L/E megascore (higher is better). · people with amyotrophic lateral sclerosis or motor neuron disease
1 finding from 1 review
Knowledge · patients taking prescribed and over‐the‐counter medications or their carers
1 finding from 1 review
Skill acquisition Mean inhaler technique score (%), higher score indicates better technique. Scale from: 0 to 100. · patients taking prescribed and over‐the‐counter medications or their carers
1 finding from 1 review
Health outcomes Bronchial obstruction (FEV), higher score indicates less bronchial obstruction. Theoretical maximum scores were 2.72 for the multimedia and 3.14 for the control group. · patients taking prescribed and over‐the‐counter medications or their carers
1 finding from 1 review
Skill acquisition Mean inhaler technique score (%), higher score indicates better technique. Scale from: 0 to 100. · patients taking prescribed and over‐the‐counter medications or their carers
1 finding from 1 review
Compliance with medication · patients taking prescribed and over‐the‐counter medications or their carers
1 finding from 1 review
Health outcomes Peak expiratory flow readings (higher readings indicate better peak flow) · patients taking prescribed and over‐the‐counter medications or their carers
1 finding from 1 review
QoL · patients taking prescribed and over‐the‐counter medications or their carers
1 finding from 1 review
Self‐efficacy · patients taking prescribed and over‐the‐counter medications or their carers
1 finding from 1 review
Skill acquisition Mean inhaler technique score (%), higher score indicates better technique. Scale from: 0 to 100. · patients taking prescribed and over‐the‐counter medications or their carers
1 finding from 1 review
Health outcomes: Drug misuse and dependence CAGE screening tool. Scale from 0 to 4. Higher score indicates greater probability of drug misuse or dependence · patients taking prescribed and over‐the‐counter medications or their carers
1 finding from 1 review
Self‐efficacy · patients taking prescribed and over‐the‐counter medications or their carers
1 finding from 1 review
Self‐efficacy Self‐efficacy for medication adherence (higher score indicates greater self‐efficacy, scale not reported) · patients taking prescribed and over‐the‐counter medications or their carers
1 finding from 1 review
Acute rejection grade II or higher · lung transplant recipients
T‐cell antibody induction showed no clear difference in acute rejection grade II or higher compared with no antibody induction (moderate certainty).
1 finding from 1 review
Acute rejection grade II or higher · lung transplant recipients
Polyclonal T‐cell antibody showed no clear difference in acute rejection grade II or higher compared with no antibody induction (moderate certainty).
1 finding from 1 review
Intervention not reported
Pain end of treatment (0‐10 scale) Higher scores indicate higher pain levels · Patients with fibromyalgia
1 finding from 1 review
Health‐related quality of life end of treatment (0‐80 scale) Higher scores indicate lower health‐related quality of life · patients with fibromyalgia
1 finding from 1 review
Intervention not reported
Negative mood end of treatment (0‐10 scale) Higher scores indicate higher negative mood levels · Patients with fibromyalgia
1 finding from 1 review